According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

In September, David Baltimore — the scientist who discovered reverse transcriptase, a breakthrough often described as one of ...

The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.

Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

The OSHWC Code, 2020 and Social Security Code enhance worker protection in pharma through risk management, medical ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the ...

Avatar: Fire & Ash stars Sam Worthington and Stephen Lang talked to us about how their characters have changed throughout the ...

Australian animal-free casein maker Eden Brew has filed the country's first regulatory application for a precision-fermented ...

The "Vaccine Development Companies Landscape: Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis" report has been added to ...

Pharmacokinetic profiling in mice following a single 5 mg/kg intraperitoneal dose revealed favorable tolerability, metabolic stability in human liver microsomes, and measurable CNS exposure, ...

DelveInsight's Hemophilia A Market Insights report includes a comprehensive understanding of current treatment practices, hemophilia A emerging drugs, market share of individual therapies, and current ...